Clinical Report: Comparative Analysis of Surgical Intervention and SBRT

Overview

This study compares the long-term outcomes of radical surgical resection and stereotactic body radiotherapy (SBRT) in patients with oligometastatic colorectal cancer (CRC). The primary endpoint was overall survival (OS), with secondary outcomes including local tumor control and treatment-related toxicity.

Background

Colorectal cancer is a leading cause of cancer-related mortality, with oligometastatic disease representing a subset that may benefit from aggressive local therapies. The management of oligometastatic CRC typically involves either surgical resection or SBRT, yet high-level evidence comparing these modalities is limited. Understanding the outcomes of these treatments is crucial for optimizing patient care and improving survival rates.

Data Highlights

No numerical data available in the provided source material.

Key Findings

• The study utilized propensity score matching to balance baseline characteristics between patients receiving surgery and those receiving SBRT.
• Overall survival was the primary endpoint, highlighting its clinical relevance in treatment evaluation.
• Secondary outcomes included local tumor control, quality of life, and treatment-related toxicity.
• Patients with oligometastatic CRC may have different prognostic factors influencing treatment decisions.
• Existing literature suggests SBRT can achieve high local control rates, but direct comparisons with surgery are needed.

Clinical Implications

Clinicians should consider both surgical resection and SBRT for patients with oligometastatic CRC, weighing the benefits and risks of each approach. The findings underscore the importance of multidisciplinary discussions in treatment planning to optimize patient outcomes.

Conclusion

This study aims to provide robust evidence to guide clinical decision-making in oligometastatic colorectal cancer, addressing a significant gap in the current literature. Further research is needed to validate these findings and refine treatment strategies.

References

1. EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases - PubMed, 2025 -- EORTC Consensus Recommendations
2. Surgery versus stereotactic body radiotherapy for oligometastatic colorectal cancer: a prospective cohort study with propensity score matching - PMC, 2025 -- Study on SBRT vs Surgery
3. Updates in Surgery — Laparoscopic Resection as a Feasible Approach for T4 Colon Cancer: Insights from a Propensity Score Matched Study
4. Journal of Gastroenterology — Outcomes of Surgical Intervention Versus Chemoradiotherapy Following Endoscopic Resection for pT1a-MM with Lymphovascular Invasion or pT1b Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score-Matched Analysis from Japan
5. Association of Preoperative Statin Use with Survival Outcomes After Colorectal Cancer Surgery: A National Cohort Study Utilizing Propensity Score Matching
6. Journal of Neuro-Oncology — Evaluation of Intraoperative Radiotherapy Outcomes for Brain Metastases: Findings from a Prospective Observational Study with Matched-Pair Comparison
7. EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases - PubMed
8. Surgery versus stereotactic body radiotherapy for oligometastatic colorectal cancer: a prospective cohort study with propensity score matching - PMC
9. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - ScienceDirect